葡萄糖类抗生素保罗米辛A的总合成
Jie Chen1,2, Yi Ai2, Hailin Wang1,2
1Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China.
Journal of the American Chemical Society
|February 27, 2026
概括
科学家们首次实现了保罗米辛A的全合成,保罗米辛A是一种针对格拉姆阳性病原体的强效抗生素. 这一突破克服了分子的复杂性和不稳定性,为药物开发铺平了道路.
科学领域:
- 有机化学 有机化学
- 药用化学 医学化学
- 合成生物学 合成生物学
背景情况:
- 保罗米辛A是一种甘氨酸类抗生素,对抗格拉姆阳性病原体具有显著活性.
- 它的复杂结构和化学不稳定性阻碍了药物开发和合成研究.
- 之前合成保罗素A的努力受到这些挑战的限制.
研究的目的:
- 为了实现第一个保罗米辛A的全合成.
- 开发新的合成策略来克服分子固有的不稳定性和复杂性.
- 为了使未来的药物开发和保罗氨酸A类似物的探索.
主要方法:
- 开发了一种合成序列,利用高度选择性的转化,以适应paulomycin A的反应性.
- 采用WAN糖化处理以实现高效的C-糖化,产生含有氨酸的C-糖化物.
- 利用金催化Yu O-糖化与溶剂控制的异构立体控制.
- 包含一个晚期的选择性化/[3,3]-sigmatropic重新排列,以附加paulic酸碎片.
主要成果:
- 成功完成了第一个保罗米辛A的全合成.
- 证明了构建复杂的糖化物结构的高效方法.
- 确立了关键的转化,包括新的C-糖化和立体选择性的O-糖化策略.
结论:
- 已经实现了paulomycin A的总合成,克服了重要的化学挑战.
- 开发的合成途径为生产保罗氨酸A及其类似物提供了可行的途径.
- 这种合成为药物化学探索和保罗素A的潜在治疗应用开辟了新的途径.
更多相关视频
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
19.1K
09:10Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
2.8K
相关概念视频
Peptidoglycan Synthesis
3.4K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
3.4K
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
Biosynthesis in Bacteria
843
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
843
